Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Inclusion Criteria:

• Ability to understand and the willingness to sign a written informed consent document
• Participant must be 18 years of age or older
• Confirmed diagnosis of atopic dermatitis

Exclusion Criteria:

• Enrolled in another research study
• Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
• Inability to provide written informed consent

Patients with atopic dermatitis who are actively considering enrolling in a clinical study for said condition, but have not yet completed enrollment and randomization.